{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06011408",
            "orgStudyIdInfo": {
                "id": "#23-002"
            },
            "secondaryIdInfos": [
                {
                    "id": "R43MH114763",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/R43MH114763"
                }
            ],
            "organization": {
                "fullName": "iRxReminder",
                "class": "INDUSTRY"
            },
            "briefTitle": "Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes",
            "officialTitle": "Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes",
            "therapeuticArea": [
                "Dermatology"
            ],
            "study": "remote-monitoring-and-detecting-of-tardive-dyskinesia-for-improving-patient-outcomes"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-05-30",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-11-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-08-21",
            "studyFirstSubmitQcDate": "2023-08-21",
            "studyFirstPostDateStruct": {
                "date": "2023-08-25",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-07",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "iRxReminder",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "National Institute of Mental Health (NIMH)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The study is being conducted to validate the feasibility of remote assessment of Tardive Dyskinesia.",
            "detailedDescription": "The study is being conducted to validate the feasibility of remote assessment of Tardive Dyskinesia. Participants will all be taking an antipsychotic medication and half will have a diagnosis of Tardive Dyskinesia and half will not. Participant responses to interview questions and elements of the Abnormal Involuntary Movement Scale will be collected on video. The videos will be rated by trained observers. Machine learning methods will be used to develop an algorithm to detect abnormal movements in individuals with a known Tardive Dyskinesia diagnosis. The trained rater results will be compared to the algorithm to determine the accuracy of the algorithm."
        },
        "conditionsModule": {
            "conditions": [
                "Tardive Dyskinesia"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Open-label, observational study with two groups taking antipsychotic with or without Tardive Dyskinesia",
                "primaryPurpose": "SCREENING",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 300,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Taking antipsychotic medication with Tardive Dyskinesia",
                    "type": "OTHER",
                    "interventionNames": [
                        "Other: TDtect"
                    ]
                },
                {
                    "label": "Taking antipsychotic medication without Tardive Dyskinesia",
                    "type": "OTHER",
                    "interventionNames": [
                        "Other: TDtect"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "TDtect",
                    "description": "Collecting video data on abnormal movement",
                    "armGroupLabels": [
                        "Taking antipsychotic medication with Tardive Dyskinesia",
                        "Taking antipsychotic medication without Tardive Dyskinesia"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "AIMS Score",
                    "description": "Abnormal Involuntary Scale Score",
                    "timeFrame": "Baseline"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\nFor the non-TD group:\n\n1. Prescribed and taking an antipsychotic medication for 90-days or longer.\n2. Tardive Dyskinesia symptoms if present are not from Parkinsons, Tourette's syndrome, Huntington disease.\n3. Signed an informed consent.\n4. Speaks English fluently.\n\nExclusion Criteria:\n\n1. Suffered a moderate or severe head injury in the last year;\n2. History of a learning disorder or developmental disability that would inhibit a patient from completing the TD protocol.\n3. Severe visual impairment that is cannot be corrected by glasses or contacts.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Anthony Sterns, Ph.D.",
                    "role": "CONTACT",
                    "phone": "3306066675",
                    "email": "asterns@irxreminder.com"
                },
                {
                    "name": "Fred Ma, M.D., Ph.D.",
                    "role": "CONTACT",
                    "phone": "2164695725",
                    "email": "fma@irxreminder.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Rakesh Ranjan, M.D.",
                    "affiliation": "Charak Research Center",
                    "role": "STUDY_DIRECTOR"
                },
                {
                    "name": "Owen Muir, M.D.",
                    "affiliation": "Fermata Health",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Fermata Helath",
                    "status": "RECRUITING",
                    "city": "Brooklyn",
                    "state": "New York",
                    "zip": "10038",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Nogga Schwartz",
                            "role": "CONTACT",
                            "phone": "917-634-4648",
                            "email": "nogga.schwartz@fermata.health"
                        },
                        {
                            "name": "Owen Muir, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.6501,
                        "lon": -73.94958
                    }
                },
                {
                    "facility": "Charak Research Center",
                    "status": "RECRUITING",
                    "city": "Garfield Heights",
                    "state": "Ohio",
                    "zip": "44125",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kenzie Miller",
                            "role": "CONTACT",
                            "phone": "216-280-6374",
                            "email": "kmiller@atcharakcenter.com"
                        },
                        {
                            "name": "Rakesh Ranjan, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.417,
                        "lon": -81.60596
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Related Info",
                    "url": "http://www.irxreminder.com"
                },
                {
                    "label": "Related Info",
                    "url": "http://www.charakcenter.com"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000020820",
                    "term": "Dyskinesias"
                },
                {
                    "id": "D000071057",
                    "term": "Tardive Dyskinesia"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009069",
                    "term": "Movement Disorders"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000004409",
                    "term": "Dyskinesia, Drug-Induced"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M22574",
                    "name": "Dyskinesias",
                    "asFound": "Dyskinesia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M680",
                    "name": "Tardive Dyskinesia",
                    "asFound": "Tardive Dyskinesia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12029",
                    "name": "Movement Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M7583",
                    "name": "Dyskinesia, Drug-Induced",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M16904",
                    "name": "Antipsychotic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "PsychDr",
                    "name": "Psychotropic Drugs"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}